Paolo Romero

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

Razelle Kurzrock, Mordechai Shtalrid, Paolo Romero et al. · Nature · 1987 · 274 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +7

Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.

M Shtalrid, Moshe Talpaz, Mark Blick et al. · Journal of Clinical Oncology · 1988 · 49 citations

Bcr Rearrangement, Mixed-phenotype Acute Leukemia, Pathology +18

Molecular characteristics of chronic myelogenous leukemia in blast crisis

Mark Blick, Paolo Romero, Moshe Talpaz et al. · Cancer Genetics and Cytogenetics · 1987 · 44 citations

Hematological Malignancy, Chromatin, Medicine +6

Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature

Kavita S. Reddy, Radha Satyadev, Derek Bouman et al. · Cancer Genetics and Cytogenetics · 2006 · 17 citations

Cryptic Deletion, Burkitt T, Pathology +2

Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.

Paolo Romero, Miloslav Beran, M Shtalrid et al. · PubMed · 1989 · 13 citations